Article Text

Download PDFPDF
Adjustable gastric banding plus conventional therapy improved glycaemic control in obese patients with type 2 diabetes

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

J B Dixon

Dr J B Dixon, Monash University Medical School, Melbourne, Victoria, Australia; john.dixon@med.monash.edu.au

STUDY DESIGN

Design:

randomised controlled trial.

Allocation:

unclear concealment.*

Blinding:

unblinded.*

STUDY QUESTION

Setting:

University Obesity Research Center in Melbourne, Victoria, Australia.

Patients:

60 participants 20–60 years of age (mean age 47 y, 53% women) who had a body mass index of 30–40 kg/m2, had been diagnosed with type 2 diabetes within the previous 2 years, and did not have renal impairment or diabetic retinopathy. Exclusion criteria were type 1 diabetes, diabetes secondary to a specific disease, or previous bariatric surgery; medical problems such as mental impairment, drug or alcohol addiction, recent major vascular events, internal malignancy, or portal hypertension; contraindications to either study intervention; and failure to attend 2 initial information visits.

Intervention:

LAGB using the pars flaccida technique plus CT (n = 30) or CT alone (n = 30). CT comprised access to a …

View Full Text

Footnotes

  • Source of funding: Allergan Health (unrestricted grant to Monash University and provided gastric bands) and Applied Medical (provided laparoscopic parts).